Synapse - Stanley W. Liang

Stanley W. Liang

Research Focus

Medicine; Research Project Associate

Recent additions – View all

Cutaneous toxicity and clinical outcomes with enfortumab vedotin and pembrolizumab in patients with locally advanced or metastatic urothelial carcinoma
Meeting Abstract

Arbuiso, A.; Sternschuss, M.; Whiting, K.; Gupta, A.; Huttenlocher Bent, E.; Alvarez, N.; Regazzi, A. M.; Liang, S.; Ahmed, F.; Akin, O.; more...
Journal of Clinical Oncology (2025)

Fulltext@MSK | Save
Treatment patterns and clinical outcomes with platinum-based chemotherapy after enfortumab vedotin and pembrolizumab in patients with metastatic urothelial carcinoma
Meeting Abstract

Sternschuss, M.; Whiting, K.; Arbuiso, A.; Gupta, A.; Bent, E. H.; Alvarez, N.; Regazzi, A. M.; Liang, S.; Ahmed, F.; Akin, O.; more...
Journal of Clinical Oncology (2025)

Fulltext@MSK | Save
Characterizing the immune effects of enfortumab vedotin (EV) on peripheral blood mononuclear cells (PBMCs) in metastatic urothelial cancer patients (mUC)
Meeting Abstract

Gupta, A.; Sevilla, C.; Pihlstrom, N. L.; Liang, S.; Regazzi, A. M.; McCoy, A. S.; Maher, C. A.; Wong, P.; Ahmed, F.; Funt, S. A.; more...
Journal of Clinical Oncology (2025)

Fulltext@MSK | Save

Co-authors at MSK

3

Aggen
3

Ahmed
3

Bajorin
3

Funt
3

Gupta
3

Iyer
3

Regazzi
3

Rosenberg
2

Akin
2

Alvarez
2

Arbuiso
2

Bent
2

Beylergil
2

Ostrovnaya
2

Sternsc...
2

Whiting
1

Maher
1

McCoy
1

Osorio
1

Teo
1

Wong

Types of Work

Publications

Journal of Clinical Oncology (3)